Home Tags Cancer: Prostate

Tag: Cancer: Prostate

For patients with prostate cancer

ADT May Up Risk for Heart Failure in Prostate Cancer Patients

Heart failure risk higher for androgen deprivation therapy users in propensity score-matched analysis
A lack of understanding of terminology

Barriers to Prostate Cancer Research in Black Men Identified

Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation

The American Society for Radiation Oncology, Oct. 21-24

The 60th Annual Meeting of the American Society for Radiation Oncology The annual meeting of the American Society for Radiation Oncology...
A new clinical guideline for early-stage prostate cancer supports the use of shortened courses of radiation therapy

Hypofractionated Radiation OK for Localized Prostate CA

New multidisciplinary guideline for early-stage prostate cancer developed by three professional societies
For men with low- and intermediate-risk prostate cancer

ASTRO: Long-Term Benefit for Stereotactic Radn in Prostate CA

Trials show high survival rates, freedom from recurrence for low-, intermediate-risk prostate cancer
Midlife levels of prostate-specific antigen strongly predict future development of aggressive prostate cancer among black men

Midlife PSA Predicts Aggressive Prostate Cancer in Black Men

Findings suggest potential for a targeted screening approach based on midlife PSA
Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging

Guideline-Discordant Prostate Cancer Imaging Up With Medicare

Patients in VA and Medicare group, VA-only group less likely to receive guideline-discordant imaging
Prostate cancer screening with prostate-specific antigen testing is not recommended

PSA Testing Not Recommended for Prostate Cancer Screening

Odds of choosing screening up for men with family history, African descent, low socioeconomic status
The incidence of treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC) is 17 percent among patients with metastatic castration-resistant prostate cancer

Advanced Prostate Cancer Variant More Common Than Thought

Incidence of tx-emergent small-cell neuroendocrine prostate cancer 17 percent among those with mCRPC
The automated Bone Scan Index is an independent prognostic imaging biomarker of overall survival in metastatic castration-resistant prostate cancer

Automated Bone Scan Index Prognostic for Prostate Cancer

aBSI validated as prognostic biomarker of survival in metastatic castration-resistant prostate cancer